Stay away from Ranbaxy: Baliga

39818 Investors following Ranbaxy Labs. Share this News with them.

0

Like this story, share it with millions of investors on M3

Stay away from Ranbaxy: Baliga

Ambareesh Baliga of Karvy Stock Broking is of the opinion that one should stay away Ranbaxy Laboratories because it is going more towards the levels of Rs 400, so closer to Rs 400 or Rs 410, it makes sense in investing in this company for slightly longer term perspective.

Post your opinion here

 

0

Tweet

Share on Tumblr

Excerpts from Bazaar on CNBC-TV18 Watch the full show » RELATED NEWS Ranbaxy Laboratories continues to fall Vijay not bullish on Ranbaxy Ranbaxy open offer to close on Sept 4 ALSO READ See previous views by Ambareesh Baliga See what other Experts & Brokerages are saying about Ranbaxy Labs See messages about Ranbaxy Labs Ranbaxy Labs BSE | NSE 28/05/12 Are Mutual Funds betting on Ranbaxy Labs?

Ambareesh Baliga of Karvy Stock Broking is of the opinion that one should stay away Ranbaxy Laboratories .

Baliga told CNBC-TV18, "For the time being I would say stay away from Ranbaxy because we see it going more towards the levels of Rs 400, so closer to Rs 400 or Rs 410, it makes sense in investing in this company for slightly longer term perspective. For the time being one should ignore it because clearly post this open offer, the price should go down to levels of Rs 400 to Rs 410."

Disclosure: It is safe to assume that analyst and his client may have an investment interest in the above stock/sector.